364 related articles for article (PubMed ID: 28475848)
1. Beyond Positive Margins and Extracapsular Extension: Evaluating the Utilization and Clinical Impact of Postoperative Chemoradiotherapy in Resected Locally Advanced Head and Neck Cancer.
Trifiletti DM; Smith A; Mitra N; Grover S; Lukens JN; Cohen RB; Read P; Mendenhall WM; Lin A; Swisher-McClure S
J Clin Oncol; 2017 May; 35(14):1550-1560. PubMed ID: 28475848
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
[TBL] [Abstract][Full Text] [Related]
3. Utilization and Survival of Postoperative Radiation or Chemoradiation for pT1-2N1M0 Head and Neck Cancer.
Lee A; Givi B; Roden DF; Tam MM; Wu SP; Gerber NK; Hu KS; Schreiber D
Otolaryngol Head Neck Surg; 2018 Apr; 158(4):677-684. PubMed ID: 29256329
[TBL] [Abstract][Full Text] [Related]
4. Patterns of care and outcomes of adjuvant therapy for high-risk head and neck cancer after surgery.
Osborn VW; Givi B; Rineer J; Roden D; Sheth N; Lederman A; Katsoulakis E; Hu K; Schreiber D
Head Neck; 2018 Jun; 40(6):1254-1262. PubMed ID: 29451961
[TBL] [Abstract][Full Text] [Related]
5. Extent of pathologic extracapsular extension and outcomes in patients with nonoropharyngeal head and neck cancer treated with initial surgical resection.
Prabhu RS; Hanasoge S; Magliocca KR; Moeller BJ; Milas ZL; Hall WA; El-Deiry M; Wadsworth JT; Higgins KA; Beitler JJ
Cancer; 2014 May; 120(10):1499-506. PubMed ID: 24510454
[TBL] [Abstract][Full Text] [Related]
6. Assessment of adjuvant therapy in resected head and neck cancer with high-risk features.
Ajmani GS; Nocon CC; Wang CH; Bhayani MK
Oral Oncol; 2017 Nov; 74():15-20. PubMed ID: 29103745
[TBL] [Abstract][Full Text] [Related]
7. Patterns of Care and Comparative Effectiveness of Intensified Adjuvant Therapy for Resected Oropharyngeal Squamous Cell Carcinoma in the Human Papillomavirus Era.
Sher DJ; Nedzi L; Khan S; Hughes R; Sumer BD; Myers LL; Truelson JM; Koshy M
JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):777-88. PubMed ID: 27368076
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemoradiation does not improve survival in elderly patients with high-risk resected head and neck cancer.
Giacalone NJ; Qureshi MM; Mak KS; Kirke D; Patel SA; Shah BA; Salama AR; Jalisi S; Truong MT
Laryngoscope; 2018 Apr; 128(4):831-840. PubMed ID: 28833217
[TBL] [Abstract][Full Text] [Related]
9. Quantitative lymph node burden as a 'very-high-risk' factor identifying head and neck cancer patients benefiting from postoperative chemoradiation.
Zumsteg ZS; Luu M; Kim S; Tighiouart M; Mita A; Scher KS; Lu DJ; Shiao SL; Mallen-St Clair J; Ho AS
Ann Oncol; 2019 Jan; 30(1):76-84. PubMed ID: 30395159
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors Associated with Disease Recurrence in Patients with Stage III/IV Squamous Cell Carcinoma of the Oral Cavity Treated with Surgery and Postoperative Radiotherapy.
Noble AR; Greskovich JF; Han J; Reddy CA; Nwizu TI; Khan MF; Scharpf J; Adelstein DJ; Burkey BB; Koyfman SA
Anticancer Res; 2016 Feb; 36(2):785-92. PubMed ID: 26851040
[TBL] [Abstract][Full Text] [Related]
11. The role of adjuvant therapy in the management of head and neck merkel cell carcinoma: an analysis of 4815 patients.
Chen MM; Roman SA; Sosa JA; Judson BL
JAMA Otolaryngol Head Neck Surg; 2015 Feb; 141(2):137-41. PubMed ID: 25474617
[TBL] [Abstract][Full Text] [Related]
12. Role of adjuvant chemoradiotherapy in T4N0 stage IV head and neck cancer: A National Cancer Database analysis.
Kirke DN; Qureshi MM; Kamran SC; Ezzat W; Jalisi S; Salama A; Everett PC; Truong MT
Head Neck; 2018 Jun; 40(6):1174-1184. PubMed ID: 29417687
[TBL] [Abstract][Full Text] [Related]
13. Phase III randomized trial of preoperative concurrent chemoradiotherapy versus preoperative radiotherapy for patients with locally advanced head and neck squamous cell carcinoma.
Yi J; Huang X; Xu Z; Liu S; Wang X; He X; Luo D; Luo J; Xiao J; Zhang S; Wang K; Qu Y; Tang Y; Liu W; Xu G; Gao L; Wang D
Oncotarget; 2017 Jul; 8(27):44842-44850. PubMed ID: 28179586
[TBL] [Abstract][Full Text] [Related]
14. Evolution of treatment and high-risk features in resectable locally advanced Head and Neck squamous cell carcinoma with special reference to extracapsular extension of nodal disease.
Krstevska V
J BUON; 2015; 20(4):943-53. PubMed ID: 26416042
[TBL] [Abstract][Full Text] [Related]
15. Traditional risk factors and nodal yield-still relevant with high-quality risk-adapted adjuvant treatment for locally advanced head and neck cancer?
Butt Y; Tennstedt P; Busch CJ; Hanken H; Krüll A; Petersen C; Tribius S
Strahlenther Onkol; 2023 Mar; 199(3):284-292. PubMed ID: 36350358
[TBL] [Abstract][Full Text] [Related]
16. Histological assessment of cervical lymph node identifies patients with head and neck squamous cell carcinoma (HNSCC): who would benefit from chemoradiation after surgery?
Wan XC; Egloff AM; Johnson J
Laryngoscope; 2012 Dec; 122(12):2712-22. PubMed ID: 23060119
[TBL] [Abstract][Full Text] [Related]
17. Postoperative radiotherapy in head and neck carcinoma with extracapsular lymph node extension and/or positive resection margins: a comparative study.
Huang DT; Johnson CR; Schmidt-Ullrich R; Grimes M
Int J Radiat Oncol Biol Phys; 1992; 23(4):737-42. PubMed ID: 1618666
[TBL] [Abstract][Full Text] [Related]
18. Phase II feasibility trial of adjuvant chemoradiotherapy with 3-weekly cisplatin for Japanese patients with post-operative high-risk squamous cell carcinoma of the head and neck.
Kiyota N; Tahara M; Okano S; Kawashima M; Matsuura K; Onozawa Y; Nibu K; Hayashi R; Yoshimura K; Ohtsu A
Jpn J Clin Oncol; 2012 Oct; 42(10):927-33. PubMed ID: 22923484
[TBL] [Abstract][Full Text] [Related]
19. Postoperative chemoradiotherapy in patients with head and neck cancer aged 70 or older with positive margins or extranodal extension and the influence of nodal classification.
Yoshida EJ; Luu M; David JM; Kim S; Mita A; Scher K; Shiao SL; Tighiouart M; Ho AS; Zumsteg ZS
Head Neck; 2018 Jun; 40(6):1228-1236. PubMed ID: 29417700
[TBL] [Abstract][Full Text] [Related]
20. Utility of up-front transoral robotic surgery in tailoring adjuvant therapy.
Gildener-Leapman N; Kim J; Abberbock S; Choby GW; Mandal R; Duvvuri U; Ferris RL; Kim S
Head Neck; 2016 Aug; 38(8):1201-7. PubMed ID: 27225507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
